Association of Early Nasopharyngeal Immune Markers With COVID-19 Clinical Outcome: Predictive Value of CCL2/MCP-1

Beatríz Sierra, Ana Beatriz Alvarez Pérez, E. Aguirre, Claudia Bracho, Odalys Valdés, Narciso Jiménez, Waldemar Baldoquín Rodríguez, Guelsys González, Lilia M Ortega, Maria Caridad Montalvo,

Open Forum Infectious Diseases · 2020 · 24 citations · 7 references

DOIFull text

Open access

Concepts

Abstract

Early recognition of severe forms of coronavirus disease 2019 (COVID-19) is essential for an opportune and effective intervention, reducing life-risking complications. An altered inflammatory immune response seems to be associated with COVID-19's pathogenesis and progression to severity. Here we demonstrate the utility of early nasopharyngeal swab samples for detection of the early expression of immune markers and the potential value of CCL2/MCP-1 in predicting disease outcome.

References

7